Enfagrow Premium Toddler Transitions
Allegations: Deceptively marketing products as “nutritionally appropriate” for children between nine and eighteen months
Enfamil Infant Formulas
Case Name (Date)
Martinez et al. v. Mead Johnson & Co., LLC
22-cv-213, C.D. Cal.
(Feb. 2022)
Product/Service
Several Enfamil infant formulas, including Gentlease, Enspire Gentlease, NeuroPro Gentlease, and NeuroPro Sensitive
Allegations
Misleadingly marketing formulas as “Milk-based Powder[s]” when the primary ingredient is dried corn syrup, which is a form of sugar
Status
Pending
Class-Action Tracker
Enfamil and Enfamil Premature
Allegations: Falsely marketing products as safe when they are dangerous for premature infants
Enfamil Infant Formula
Allegations: Failing to disclose that products contain toxic heavy metals
Enfamil Baby Formula Powders
Allegations: Products do not contain enough powder to make the advertised number of bottles
The Latest
TINA’s List
Readers have told us to look into these MLMs.
Advertising of Supplement Targeting Seniors Questioned
TINA.org Joins with AARP in Objecting to Move Free Class-Action Settlement MADISON, Conn., March 12, 2015 — More than 46 million people suffer from arthritis, many of them elderly, and…
Lawsuits: Glucosamine’s Promised Relief Mostly Marketing Hype
Consumers report adverse reactions.
Proposed Glucosamine Settlement Stiffs Consumers
Class-action settlement over supplement sold by Walmart, Walgreens and Supervalu provides little relief to consumers.
